trending Market Intelligence /marketintelligence/en/news-insights/trending/owrgybkjkrz-8uqhnb3kpw2 content esgSubNav
In This List

BARD1 Life Sciences plans to raise A$1.3M via placement of shares

Blog

Gauging Supply Chain Risk In Volatile Times

Blog

Insight Weekly: Banks' efficiency push; vacuuming carbon; Big Pharma diversity goals

Blog

The Future of Risk Management Digitization in Credit Risk Management

Blog

Climate Credit Analytics: Diving into the model


BARD1 Life Sciences plans to raise A$1.3M via placement of shares

BARD1 Life Sciences Ltd. agreed to sell 86,666,666 shares at 1.5 Australian cents each to a group of investors.

The company expects to raise A$1.3 million through the placement, which will go toward its ongoing research and development programs, as well as commercial initiatives and general working capital purposes.

The placement is expected to settle by March 26.

Australia-based BARD1 Life Sciences develops therapies and diagnostic tests for cancer.